Literature DB >> 19200803

Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.

Rosa M Marion1, Katerina Strati, Han Li, Agueda Tejera, Stefan Schoeftner, Sagrario Ortega, Manuel Serrano, Maria A Blasco.   

Abstract

Telomere shortening is associated with organismal aging. iPS cells have been recently derived from old patients; however, it is not known whether telomere chromatin acquires the same characteristics as in ES cells. We show here that telomeres are elongated in iPS cells compared to the parental differentiated cells both when using four (Oct3/4, Sox2, Klf4, cMyc) or three (Oct3/4, Sox2, Klf4) reprogramming factors and both from young and aged individuals. We demonstrate genetically that, during reprogramming, telomere elongation is usually mediated by telomerase and that iPS telomeres acquire the epigenetic marks of ES cells, including a low density of trimethylated histones H3K9 and H4K20 and increased abundance of telomere transcripts. Finally, reprogramming efficiency of cells derived from increasing generations of telomerase-deficient mice shows a dramatic decrease in iPS cell efficiency, a defect that is restored by telomerase reintroduction. Together, these results highlight the importance of telomere biology for iPS cell generation and functionality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200803     DOI: 10.1016/j.stem.2008.12.010

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  208 in total

Review 1.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 2.  Nuclear reprogramming to a pluripotent state by three approaches.

Authors:  Shinya Yamanaka; Helen M Blau
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 3.  Mammalian cell dedifferentiation as a possible outcome of stress.

Authors:  Ofer Shoshani; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

4.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

5.  Telomere length and iPSC re-programming: survival of the longest.

Authors:  Richard Allsopp
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

6.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

Review 7.  Pluripotent stem cells: origin, maintenance and induction.

Authors:  Maria P De Miguel; Sherezade Fuentes-Julián; Yago Alcaina
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

Review 8.  Nuclear reprogramming and epigenetic rejuvenation.

Authors:  Prim B Singh; Fred Zacouto
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

Review 9.  Embryonic and induced pluripotent stem cells as a model for liver disease.

Authors:  Hiroshi Yagi; Edgar Tafaleng; Masaki Nagaya; Marc C Hansel; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 10.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.